- Release Date: 22/03/22 08:38
- Summary: Orphan Drug Designation Granted to Noxopharm by US FDA
- Price Sensitive: Yes
- Download Document 215.28KB
- Forums
- ASX - By Stock
- NOX
- Ann: Orphan Drug Designation Granted to Noxopharm by US FDA
NOX
noxopharm limited
Add to My Watchlist
7.62%
!
9.7¢

Ann: Orphan Drug Designation Granted to Noxopharm by US FDA
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.7¢ |
Change
-0.008(7.62%) |
Mkt cap ! $28.34M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.7¢ | $689 | 7.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 108477 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 55289 | 0.098 |
2 | 73788 | 0.097 |
2 | 53773 | 0.093 |
2 | 60398 | 0.092 |
1 | 10989 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 108477 | 3 |
0.110 | 51000 | 4 |
0.115 | 55816 | 3 |
0.130 | 5500 | 1 |
0.135 | 49390 | 2 |
Last trade - 10.06am 11/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online